Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9880208 | Journal of the Neurological Sciences | 2005 | 5 Pages |
Abstract
Lymphocyte-specific protein tyrosine kinase (LCK) is a lymphoid-specific, Src family protein tyrosine kinase that is known to play a pivotal role in T-cell activation and interact with the T-cell coreceptors, CD4 and CD8. It has been shown to be significantly down-regulated in Alzheimer disease (AD) hippocampus compared with non-demented controls. Furthermore, it is located in a previously identified genetic linkage region (1p34-36) associated with AD. Therefore, we consider it to be a candidate gene for AD. We examined the relationship between AD and the LCK and apolipoprotein E (APOE) genes in 376 AD (including 323 late-onset AD (LOAD) cases and 53 early-onset AD (EOAD) cases) and 378 non-demented controls using a single nucleotide polymorphism (SNP). The polymorphism in intron 1 (+ 6424 A/G) was significantly associated with AD risk. The odds ratio (OR) for total AD associated with the GG genotype was 1.41 (95% CI = 1.06-1.87) and that for LOAD was 1.37 (95%CI = 1.02-1.85), while that for APOE-ε4 was 5.06 (95% CI = 3.60-7.12). In the APOE-ε4 non-carrier subgroup, the GG genotype also showed significant association (OR = 1.66; 95% CI = 1.16-2.38). These results indicate that the LCK is a novel risk gene for AD regardless of the APOE genotype.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Wangtao Zhong, Hidehisa D. Yamagata, Keiko Taguchi, Hiroyasu Akatsu, Kouzin Kamino, Takayuki Yamamoto, Kenji Kosaka, Masatoshi Takeda, Ikuko Kondo, Tetsuro Miki,